The present invention provides compositions and methods for the detection
and characterization of HCV sequences. More particularly, the present
invention provides compositions, methods and kits for using invasive
cleavage structure assays (e.g. the INVADER assay) to screen nucleic acid
samples, e.g., from patients, to determine HCV genotype.